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Abstract
Background: Anti-glomerular basement membrane (GBM) antibody disease is a rare autoimmune disorder
characterized by rapidly progressive glomerulonephritis caused by autoantibodies against the α3-chain of type IV
collagen in the GBM.
Case presentation: An 8-year-old girl with hematuria and proteinuria due to anti-GBM nephritis was diagnosed with
hematuria and proteinuria during a school urine screening program. Her blood pressure and serum creatinine levels
were normal. Her hematuria and proteinuria persisted for several months. Since a spot urine protein to creatinine ratio
was around 7 g/g Cre, a percutaneous renal biopsy was performed. Immnofluorescent staining demonstrated a linear
pattern for immunoglobulin G along the entire GBM. Chest computed tomography was normal. Anti-GBM antibody
assays were reported as slightly raised; thus, the diagnosis was anti-GBM disease with normal renal function. Treatment
included plasma exchange, intravenous high-dose methylprednisolone, and cyclophosphamide as a mainstay
medication. The treatment was rapidly effective with an immediate decrease in anti-GBM titers and proteinuria.
Conclusions: Cases of anti-GBM disease with normal renal function in children are rare. Treatment in children has not
been established; therefore, clinicians need to carefully select an effective treatment because the prognosis is poor.
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Background
Anti-glomerular basement membrane (GBM) disease
is included among immune complex small vessel vas-
culitides. This disease is a vasculitis that affects the
glomerular capillaries, pulmonary capillaries, or both,
with GBM deposition of anti-GBM autoantibodies.
Lung involvement causes pulmonary hemorrhage, and
renal involvement causes glomerulonephritis with ne-
crosis and crescents [1]. It has a frequency of 0.5–1
case per million/year. All age groups can be affected,
but the peak incidence occurs in the third decade in
young men with a second peak in the sixth and sev-
enth decades, which affects men and women equally.
Although anti-GBM disease in childhood is quite uncom-
mon, we observed anti-GBM disease in an 8-year-old girl
with normal renal function who had participated in a
school urine screening program.
Case presentation
An 8-year-old girl was diagnosed with hematuria and
proteinuria during a school urine screening program.
She was referred to the medical outpatient clinic. Her
clinical examination and serum creatinine level were
normal. She had no medical or family history of this
condition. A spot urine protein to creatinine ratio was
around 7 g/g Cre. She was admitted to our department
because of persistent hematuria and proteinuria. Again,
the clinical examination was normal. Results of the
blood tests were as follows: white blood cell count,
10.6 × 109/L; hemoglobin level, 11.6 g/dL; platelet count,
240 × 109/L; sodium level, 135 mmol/L; potassium level,
3.7 mmol/L; total protein level, 5.56 g/dL; albumin
level, 2.67 g/dL; urea, 13.9 mg/dL; creatinine level,
0.40 mg/dL; triglyceride level, 56 mg/dL; total choles-
terol level, 267 mg/dL; complement component (C) 3
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level, 104 mg/dL; C4, 29 mg/dL; total complement
(CH50) level, 36.6 U/mL; immunoglobulin (Ig)-G
level, 766 mg/dL; and IgA level 137 mg/dL. At admis-
sion, urinalysis showed microscopic hematuria and
proteinuria. A spot urine protein to creatinine ratio
was 8.6 g/g Cre. During a routine inspection using
dimercaptosuccinic acid scan (DMSA) before renal
biopsy, Tc-99 m DMSA images showed a focal de-
creased uptake in the upper and lower portion of the
left kidney (Fig. 1a).
A renal biopsy was performed from the left kidney.
On light microscopy, the patient had 12 glomeruli
with no crescent formation. The glomeruli showed
mild proliferation of the mesangial cells. Immuno-
fluorescence showed linear staining of IgG along the
GBM (Fig. 1b–d). Thus, anti-GBM antibody glomer-
ulonephritis and Goodpasture syndrome were sus-
pected, and the serological workup (enzyme-linked
immunosorbent assay) was positive for anti-GBM
antibody elevation with a value of 29.6 U/mL (nor-
mal, <2 U/mL). Anti-nuclear and anti-double-stranded
deoxyribonucleic acid antibodies, antineutrophil anti-
body, antineutrophil cytoplasmic antibody, anti-proteinase
3, hepatitis B, and hepatitis C serologies were negative.
The complement levels were normal. Renal ultrasonog-
raphy was normal. Chest computed tomography did not
show diffuse alveolar hemorrhage. All the labs and path-
ology suggested anti-GBM disease.
Treatment consisted of three sessions of double-
filtration plasmapheresis (DFPP) every other day. Her
anti-GBM antibody level decreased to <2.0 U/mL.
Intravenous pulse methylprednisolone (30 mg/kg/day)
was administered for three days, and prednisone
(2 mg/kg every day on a weaning regimen) was con-
tinued. In addition, oral cyclophosphamide (2 mg/kg/
day daily for 8 weeks) was administered. The treat-
ment was rapidly effective with an immediate de-
crease in anti-GBM titers and proteinuria. There were
no side effects from the treatment. There was a scar
on the left kidney, which was observed using DMSA.
Her bladder pressure was measured after 6 months of
treatment, and we found low compliance in the blad-
der, vesicoureteral reflux (VUR)-2 of the right kidney,
and VUR3 of the left kidney.
Conclusions
This case of anti-GBM disease demonstrated the fol-
lowing three points. First, she had anti-GBM disease
with normal kidney function. Second, VUR with blad-
der dysfunction may have been the cause. Third, DFPP
is an effective treatment for anti-GBM disease with
normal kidney function.
Fig. 1 a Dimercaptosuccinic acid scan. b Immunofluorescence showing linear staining of immunoglobulin G along the glomerular basement
membrane. c Periodic acid-Schiff stain showing a scar (×40). d Periodic acid-Schiff stain showing no crescent formation (×200)
Nagano et al. BMC Nephrology  (2015) 16:185 Page 2 of 4
Anti-GBM disease remains a very uncommon condi-
tion in the pediatric population. We identified only 23
cases published in English literature over a 25-year span
[2]. Anti-GBM disease has an estimated frequency of
0.5–1 case per million inhabitants/year, according to a
series published in New Zealand, Australia, the United
Kingdom, the United States, China, and Scandinavia
[3, 4]. We described the case of an 8-year-old girl
with only minimal renal involvement and no pulmon-
ary symptoms.
Symptoms of nephritis often exhibit a clinical pic-
ture of rapidly progressive glomerulonephritis; how-
ever, to date, several cases of anti-GBM disease with
normal kidney function have been reported. The
prevalence is approximately 3–36 % [5]. Systemic
symptoms (i.e., malaise, fever, or weight loss) were
less common in patients with normal renal function
than in those with renal impairment. Circulating anti-
GBM antibodies were detected less often and at lower
levels in individuals with normal renal function than
in those with renal impairment. The histological abnor-
malities were not as marked in patients with normal renal
function compared to those with renal impairment [6].
The IgG subclasses for the distribution of natural
autoantibodies were restricted to IgG2 (100 %) and
IgG4 (100 %), whereas in patients, it was mainly IgG1
(93.8 %) and IgG4 (90.6 %) [7]. Different IgG sub-
classes have different biological properties. For ex-
ample, IgG4, unlike IgG1, does not efficiently bind to
C1q; therefore, it does not activate the classical path-
way of the complement. In addition, the IgG Fc re-
ceptors on mononuclear macrophage poorly bind to
IgG4. Thus, IgG4 is unlikely to trigger severe inflam-
matory damage to the glomeruli. Previously, we ob-
served anti-GBM antibodies in patients with mild
renal dysfunction (serum creatinine level, <300 mmol/L)
that were predominantly of the IgG4 subclasses (75 %),
which supports the speculation that IgG subclasses of
anti-GBM antibodies may be associated with different
clinical presentations and disease progression [5]. Add-
itionally, since a school urine screening system is wide-
spread in Japan, it was possible to discover this condition
early in our case.
Direct damage to the kidneys due to reflux caused
anti-GBM antibody production.
In adults, a wide variety of agents have been linked to
anti-GBM disease, including automobile exhaust, fuels
(gasoline and jet fuel), paints, solvents (organic, de-
greasing, dry-cleaning, and paint solvents), hair prod-
ucts (hair spray and hairdressing solvents), cleaners,
glue, and insecticides [8]. There have been case reports
on anti-GBM disease following lithotripsy and ureteric
obstruction, suggesting that antigens released from a
mechanically damaged kidney may initiate the disease
in susceptible individuals [9]. There may be a case in
which antibody production is caused by reflux ne-
phropathy in VUR.
We used DFPP as therapy, and the antibodies became
negative quickly. Recommendations for the treatment of
anti-GBM disease are mainly based on studies in adults.
The treatment of choice in anti-GBM disease is plasma
exchange combined with prednisone and cyclophospha-
mide. Plasma exchange can remove the anti-GBM anti-
bodies along with other inflammation mediators while
the immunomodulators lower antibody formation. We
chose DFPP because the antibody titer is low, and we se-
lected DFPP since it is efficient in terms of infection and
cost. In previous reports, DFPP was effective for treating
anti-GBM disease [10, 11]. In fact, in our case, IgG re-
moval efficiency was 60 % after the first DFPP proced-
ure, and the antibody was negative after DFPP was
performed three times. If the antibody titer is high,
plasmapheresis is superior to DFPP, and it is considered
an effective treatment that can be performed safely even
if the antibody titer is low. When the antibody titer is
high, simple plasma exchange is superior to DFPP. How-
ever, when the antibody titer is low, DFPP is an effective
treatment because it is safer and less expensive.
In a previous nationwide survey in Japan, the prog-
nosis was 80 % for anti-GBM type nephritis and 60 %
for Goodpasture syndrome, and the renal prognosis
was 50 % for anti-GBM type nephritis and 40 % for
Goodpasture syndrome. Prognosis seems to worsen if
the patient is oliguric at presentation, if the serum
creatinine is >600 μmol/L (6.8 mg/dL), or if there is >50 %
crescent formation of the glomeruli [2]. Disease recur-
rence with antibody production has been reported, but it
is quite rare.
We reported on a pediatric case of anti-GBM disease
with normal renal function. Because of the school urine
screening program, it was discovered at an early stage.
Direct damage to the kidney due to VUR is considered
the etiology in the current case. It is interesting that in
a case with renal failure due to reflux nephropathy with
VUR, anti-GBM antibody is produced. We think that
the accumulation of similar cases will help elucidate the
pathology of anti-GBM disease in children.
Consent
Written informed consent was obtained from the patient
for publication of this case report. A copy of the written
consent is available for review by the editor of this
journal.
Abbreviations
DFPP: double-filtration plasmapheresis; DMSA: dimercaptosuccinic acid scan;
GBM: anti-glomerular basement membrane; Ig: immunoglobulin; PV: plasma
volume; VUR: vesicoureteral reflux.
Nagano et al. BMC Nephrology  (2015) 16:185 Page 3 of 4
Competing interests
The authors declare that they have no competing interests.
Authors’contributions
YG, KK, and YK diagnosed and clinically monitored the patient. CN wrote the
paper. All authors read and approved the final manuscript.
Acknowledgements
None
Received: 15 June 2015 Accepted: 29 October 2015
References
1. Hellmark T, Segelmark M. Diagnosis and classification of Goodpasture's
disease (anti-GBM). J Autoimmun. 2014;48–49:108–12.
2. Bayat A, Kamperis K, Herlin T. Characteristics and outcome of Goodpasture's
disease in children. Clin Rheumatol. 2012;31:1745–51.
3. Silvariño R, Noboa O, Cervera R. Anti-glomerular basement membrane
antibodies. Isr Med Assoc J. 2014;16:727–32.
4. Salama AD, Levy JB, Lightstone L, Pusey CD. Goodpasture's disease. Lancet.
2001;358:917–20.
5. Cui Z, Zhao MH, Singh AK, Wang HY. Antiglomerular basement membrane
disease with normal renal function. Kidney Int. 2007;72:1403–8.
6. Ang C, Savige J, Dawborn J, Miach P, Heale W, Clarke B, et al. Anti-glomerular
basement membrane (GBM)-antibody-mediated disease with normal renal
function. Nephrol Dial Transplant. 1998;13:935–9.
7. Cui Z, Wang HY, Zhao MH. Natural autoantibodies against glomerular
basement membrane exist in normal human sera. Kidney Int. 2006;69:894–9.
8. Williamson SR, Phillips CL, Andreoli SP, Nailescu C. A 25-year experience
with pediatric anti-glomerular basement membrane disease. Pediatr
Nephrol. 2011;26:85–91.
9. Kluth DC, Rees AJ. Anti-glomerular basement membrane disease. J Am Soc
Nephrol. 1999;10:2446–53.
10. Kumazaki S, Umeda Y, Sato K, Mishima H, Ishihara T, Uzawa T. [Double
filtration plasmapheresis in case of Goodpasture's syndrome]. Nihon Kyobu
Shikkan Gakkai Zasshi. 1990;28:628–633. [Article in Japanese]
11. Hajime N, Michiko A, Atsunori K, Tatsuo K, Yuko N, Naoki O, et al. A case
report of efficiency of double filtration plasmapheresis in treatment of
Goodpasture's syndrome. Ther Apher Dial. 2009;13:373–7.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Nagano et al. BMC Nephrology  (2015) 16:185 Page 4 of 4
